Home » Topics » BioWorld Science

BioWorld Science
RSS

LGD-2226 selected as clinical candidate SARM

Sep. 12, 2001

Antiscarring PCP inhibitors in the Pfizer pipeline

Sep. 12, 2001

Novuspharma antitumor agents particularly effective against solid tumors

Sep. 12, 2001

Piperidine- and piperazine-based P2X7 receptor antagonists designed at AstraZeneca

Sep. 12, 2001

Bayer presents new integrin inhibitors, uses and pharmaceutical compositions

Sep. 12, 2001

Celltech patent reveals alpha4 integrin-inhibitory squaric acid derivatives

Sep. 12, 2001

Selective cathepsin K inhibitors synthesized and tested at Roche

Sep. 12, 2001

Amiodarone metabolite has similar long-term electrophysiological effects in dogs

Sep. 12, 2001

Novartis, QLT seek approval for expanded use of Visudyne in E.U.

Sep. 12, 2001

Targeted apoptosis research program at Antisoma expanded by newly acquired rights from NIH

Sep. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...